This paper is in the following e-collection/theme issue:

Statistical Methods for Surveillance and Population Health (156) Machine Learning (1465) Machine Learning (49) Artificial Intelligence, Machine Learning, and Natural Language Processing for Public Health (36) Infectious Diseases (non-STD/STI) (1575)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46898, first published .
Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study

Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study

Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study

Authors of this article:

Stéphanie Bougeard1 Author Orcid Image ;   Adeline Huneau-Salaun1 Author Orcid Image ;   Mikael Attia2 Author Orcid Image ;   Jean-Baptiste Richard3 Author Orcid Image ;   Caroline Demeret2 Author Orcid Image ;   Johnny Platon3 Author Orcid Image ;   Virginie Allain1 Author Orcid Image ;   Stéphane Le Vu4 Author Orcid Image ;   Sophie Goyard5 Author Orcid Image ;   Véronique Gillon6 Author Orcid Image ;   Sibylle Bernard-Stoecklin7 Author Orcid Image ;   Bernadette Crescenzo-Chaigne2 Author Orcid Image ;   Gabrielle Jones7 Author Orcid Image ;   Nicolas Rose1 Author Orcid Image ;   Sylvie van der Werf2 Author Orcid Image ;   Olivier Lantz6 Author Orcid Image ;   Thierry Rose5 Author Orcid Image ;   Harold Noël7 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Stéphanie Bougeard   1 , PhD ;   Adeline Huneau-Salaun   1 ;   Mikael Attia   2 , PhD ;   Jean-Baptiste Richard   3 , MSc ;   Caroline Demeret   2 , PhD ;   Johnny Platon   3 ;   Virginie Allain   1 ;   Stéphane Le Vu   4 , PhD ;   Sophie Goyard   5 , PhD ;   Véronique Gillon   6 , PhD ;   Sibylle Bernard-Stoecklin   7 , PhD ;   Bernadette Crescenzo-Chaigne   2 , PhD ;   Gabrielle Jones   7 ;   Nicolas Rose   1 , PhD ;   Sylvie van der Werf   2 , PhD ;   Olivier Lantz   6 * , PhD, MSc ;   Thierry Rose   5 * , PhD ;   Harold Noël   7 * , PhD

1 Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France

2 Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France

3 Data Support, Processing and Analysis Department, Santé publique France, Saint-Maurice, France

4 EPI-PHARE, Saint-Denis, France

5 Diagnostic Test Innovation and Development Core Facility, Institut Pasteur, Paris, France

6 Clinical Immunology Laboratory, Institut Curie, Paris, France

7 Infectious Disease Division, Santé publique France, Saint-Maurice, France

*these authors contributed equally

Corresponding Author:

  • Stéphanie Bougeard, PhD
  • Epidemiology, Health and Welfare
  • Laboratory of Ploufragan-Plouzané-Niort
  • French Agency for Food, Environmental, Occupational Health & Safety
  • BP 53 - Technopole Saint Brieuc Armor
  • Ploufragan, 22440
  • France
  • Phone: 33 296010150
  • Email: stephanie.bougeard@anses.fr